AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Gastric Ulcers: Rebamipide is commonly used for the treatment of gastric ulcers. It helps to protect the gastric mucosa from damage caused by stomach acid and other irritants, thus promoting healing and reducing symptoms such as pain and discomfort.
Duodenal Ulcers: Similarly, rebamipide is effective in the treatment of duodenal ulcers, which are ulcers that develop in the first part of the small intestine (duodenum). By enhancing mucosal defense mechanisms, rebamipide aids in the healing of duodenal ulcers and alleviates associated symptoms.
Gastritis: Rebamipide is also used to manage gastritis, an inflammation of the stomach lining. It helps to reduce inflammation and protect the gastric mucosa, thereby relieving symptoms such as abdominal pain, nausea, and vomiting.
Gastroesophageal Reflux Disease (GERD): Rebamipide may be beneficial in the management of GERD by promoting the healing of esophageal mucosal damage caused by stomach acid reflux. It helps to strengthen the mucosal barrier in the esophagus, reducing symptoms such as heartburn and regurgitation.
Helicobacter pylori Eradication Therapy: Rebamipide is sometimes used as an adjunctive therapy in the treatment of Helicobacter pylori infection, a common cause of peptic ulcers. It may help to enhance the efficacy of antibiotic therapy by protecting the gastric mucosa and improving treatment outcomes.
Prevention of Nonsteroidal Anti-Inflammatory Drug (NSAID)-Induced Gastric Damage: Rebamipide has been shown to be effective in preventing gastric damage induced by NSAIDs, which are commonly used for pain relief but can cause gastrointestinal side effects such as ulcers and bleeding. Rebamipide's mucoprotective properties help mitigate these adverse effects.
Esophagitis: Rebamipide may be beneficial in the management of esophagitis, an inflammation of the esophagus often caused by acid reflux. By enhancing mucosal defense mechanisms, rebamipide can help reduce inflammation and promote healing of the esophageal mucosa.
Side Effects: Rebamipide is generally well-tolerated, with few reported side effects. Common side effects may include gastrointestinal disturbances such as diarrhea, abdominal pain, nausea, and constipation. Serious side effects are rare but may include allergic reactions or exacerbation of underlying conditions.
Dosage and Administration: Rebamipide is typically taken orally, usually before meals. The dosage and duration of treatment may vary depending on the specific condition being treated and the individual patient's response to therapy. It is essential to follow the prescribing healthcare provider's instructions carefully.
Contraindications: Rebamipide should be used with caution in patients with a history of hypersensitivity to the drug or its components. It may not be suitable for use in certain populations, such as pregnant or breastfeeding women, without careful risk-benefit assessment.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. β Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA β Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. β Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. β Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]